Dalian Huali Jinkang Pharmaceutical

Dalian Huali Jinkang Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and production of natural medicines and modernized Traditional Chinese Medicine (TCM). As a key subsidiary of the Holley Group, the company is a market leader in Ginkgo biloba-based therapies, particularly its flagship product, Jinkang (Ginkgo Biloba Extract Injection). This product is widely prescribed in China for the treatment of cardiovascular and cerebrovascular diseases, as well as peripheral circulation disorders. The company operates advanced GMP-certified manufacturing facilities in Dalian, emphasizing high-purity extraction and standardized quality control. Its business model integrates the entire value chain from botanical sourcing to clinical application, addressing the needs of an aging population through natural extracts.